Modality-DTA: Multimodality Fusion Strategy for Drug-Target Affinity Prediction.

Prediction of the drug-target affinity (DTA) plays an important role in drug discovery. Existing deep learning methods for DTA prediction typically leverage a single modality, namely simplified molecular input line entry specification (SMILES) or amino acid sequence to learn representations. SMILES or amino acid sequences can be encoded into different modalities. Multimodality data provide different kinds of information, with complementary roles for DTA prediction. We propose Modality-DTA, a novel deep learning method for DTA prediction that leverages the multimodality of drugs and targets. A group of backward propagation neural networks is applied to ensure the completeness of the reconstruction process from the latent feature representation to original multimodality data. The tag between the drug and target is used to reduce the noise information in the latent representation from multimodality data. Experiments on three benchmark datasets show that our Modality-DTA outperforms existing methods in all metrics. Modality-DTA reduces the mean square error by 15.7% and improves the area under the precisionrecall curve by 12.74% in the Davis dataset. We further find that the drug modality Morgan fingerprint and the target modality generated by one-hot-encoding play the most significant roles. To the best of our knowledge, Modality-DTA is the first method to explore multimodality for DTA prediction.

Citation

Xixi Yang, Zhangming Niu, Yuansheng Liu, Bosheng Song, Weiqiang Lu, Li Zeng, Xiangxiang Zeng. Modality-DTA: Multimodality Fusion Strategy for Drug-Target Affinity Prediction. IEEE/ACM transactions on computational biology and bioinformatics. 2023 Mar-Apr;20(2):1200-1210

Mesh Tags

PMID: 36083952

search → result